• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 213/04 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

Patent holdings for IPC class C07D 213/04

Total number of patents in this class: 233

10-year publication summary

10
18
14
18
25
14
12
22
12
5
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Merck Sharp & Dohme Corp.
2194
6
Boehringer Ingelheim International GmbH
4650
6
The Johns Hopkins University
5667
6
Nocion Therapeutics, Inc.
42
5
Novartis AG
10849
4
Gentex Corporation
1890
4
Hutchison MediPharma Limited
104
4
The Procter & Gamble Company
22017
3
Canon Inc.
39888
3
Dow AgroSciences LLC
1223
3
Takeda Pharmaceutical Company Limited
2713
3
Vertex Pharmaceuticals Incorporated
1597
3
Purdue Research Foundation
3612
3
The Cleveland Clinic Foundation
1572
3
Dana-Farber Cancer Institute, Inc.
2571
3
Rohm and Haas Electronic Materials Korea Ltd.
330
3
Shenzhen Chipscreen Biosciences Ltd.
25
3
Vanderbilt University
1901
3
MSD R & D (China) Co. LTD.
56
3
Bristol-myers Squibb Company
4898
2
Other owners 160